Login to Your Account



Financings Roundup


Wednesday, August 15, 2012

• Infinity Pharmaceuticals Inc., of Cambridge, Mass., closed its underwritten registered public offering of 6.095 million shares of common stock at $14.50; 795,000 of those shares were sold pursuant to the underwriters' exercise of an overallotment option. Gross proceeds were about $88.4 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription